Scientists hunt for clues to speed up CMT drug trials
NCT ID NCT06794489
First seen Mar 09, 2026 · Last updated Jun 23, 2026 · Updated 16 times
Summary
This study follows 75 people with CMT1A and 25 healthy volunteers over five years to track how the disease changes over time. Researchers will analyze blood and skin samples to find biomarkers that could make future therapy trials more effective. The goal is not to test a treatment, but to develop better tools for measuring whether new treatments actually work.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CMT1A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Centre
RECRUITINGGöttingen, Lower Saxony, 37075, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could identify reliable biomarkers and outcome measures that make future clinical trials for CMT therapies faster and more accurate.
What could go wrong
This is an observational study, not a treatment trial. It will not directly improve symptoms, and the biomarkers identified may still fail to predict disease progression in larger or longer studies.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.